Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1758-2652
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone ; volume:11 ; number:1 ; day:10 ; month:11 ; year:2008 ; pages:1 ; date:12.2008
Journal of the International AIDS Society / International AIDS Society ; 11, Heft 1 (10.11.2008), 1, 12.2008

Creator
Bruce, RD
Contributor
Altice, FL
Moody, DE
Lin, S.
Fang, WB
Sabo, JP
Wruck, JM
Conner, C.
Piliero, P.
Andrews, L.
Friedland, GH
SpringerLink (Online service)

DOI
10.1186/1758-2652-11-S1-P240
URN
urn:nbn:de:1111-2016052053825
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Bruce, RD
  • Altice, FL
  • Moody, DE
  • Lin, S.
  • Fang, WB
  • Sabo, JP
  • Wruck, JM
  • Conner, C.
  • Piliero, P.
  • Andrews, L.
  • Friedland, GH
  • SpringerLink (Online service)

Other Objects (12)

A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)

A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)

Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain

Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain

Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study

Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study

Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report

Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report

Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series

Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series

The use of buprenorphine/naloxone to treat borderline personality disorder: a case report

The use of buprenorphine/naloxone to treat borderline personality disorder: a case report

Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach

Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach

Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder

Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder

Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone

Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone

Transition from Oxycodone to Buprenorphine/Naloxone in a Hospitalized Patient with Sickle Cell Disease: A Case Report

Transition from Oxycodone to Buprenorphine/Naloxone in a Hospitalized Patient with Sickle Cell Disease: A Case Report

Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic

Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic

Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation

Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation

Related objects